Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

By R. McCarthy, J. Boehmer, R. Hruban, G. Hutchins, E. Kasper, J. Hare, K. Baughman. New England Journal of Medicine, 2000

816 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/86054ab1542be0a0e7e1ef23b7d09316248d2086

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. J. Januzzi
4. L. Tavazzi
5. C. Yancy
6. M. Drazner
7. Véronique L. Roger
8. M. Gheorghiade

Citations in the corpus

• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Downloa myocarditis, or it may be subacute, with an indistinct onset and better-tolerated LV dysfunction (158).”
• The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. (2007, background): “Adult and pediatric patients who present with the sudden onset of severe left ventricular failure within 2 weeks of a distinct viral illness and who have typical lymphocytic myocarditis on EMB have an excellent prognosis (41,42).”
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “in acute fulminant myocarditis, or it may be subacute, with an indistinct onset and better-tolerated LV dysfunction.(158) Prognosis”
• 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “After 11 years, 93% of patients with fulminant myocarditis were alive without heart transplantation compared with only 45% with the nonfulminant form.(614)”
• Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2013, background): “3,6– 9,16,150 Fulminant myocarditis is said to differ from (sub)acute lymphocytic myocarditis in its mode of onset, degree of haemodynamic compromise, and better outcome, but data are relatively scarce in adult patients.(150) Fulminant myocarditis of unknown aetiology is more frequent in children an”